Tuberculosis clinical trials
Access comprehensive clinical trial information for Tuberculosis through Pure Global AI's free database. This collection includes 552 clinical trials across multiple phases including N/A, Phase 1, Phase 2. Currently, 75 trials are actively recruiting participants.
Research for Tuberculosis is being conducted in China, South Africa, United States of America and 7+ other countries. Leading sponsors include University of Oxford and National Institute of Allergy and Infectious Diseases (NIAID). Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 552 clinical trials studying Tuberculosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include University of Oxford, National Institute of Allergy and Infectious Diseases (NIAID), Aeras, among others.